Overexpression of p95HER-2 receptors has also been observed as an independent prognostic factor for breast cancer cases, thus defining a group of patients with increased expression of HER-2 that demonstrates a shorter cancer-free survival period.25 The gene discussed is ERBB2; the disease is breast carcinoma.